Showing results (101-110 of 5,496) with videos related to

Sort By:
Pageof 550
Inflammatory Bowel Diseases|May 21, 2016
Natural History of Crohn's Disease in Elderly Patients Diagnosed Over the Age of 70 Years: A Population-Based StudyMathurin Fumery, Benjamin Pariente, Helene Sarter, et al.
Inflammatory Bowel Diseases|April 9, 2016
Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose ImmunosuppressionSharmeel K Wasan, Samantha Zullow, Adam Berg, et al.
Inflammatory Bowel Diseases|April 9, 2016
Crohn's Disease of the Ileoanal PouchAmy L Lightner, John H Pemberton, Edward J Loftus
Inflammatory Bowel Diseases|June 9, 2016
Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational StudyPolychronis Pavlidis, Panagiotis Stamoulos, Answar Abdulrehman, et al.
Inflammatory Bowel Diseases|June 9, 2016
Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative ColitisMarina Aloi, Giulia DʼArcangelo, Matteo Bramuzzo, et al.
Inflammatory Bowel Diseases|June 9, 2016
Preventing Overheating: Tight Control of Gut Innate Immunity in Health and DiseaseChristina Begka, Dominique Velin, Michel H Maillard
Inflammatory Bowel Diseases|June 9, 2016
Luminal Extracellular Vesicles (EVs) in Inflammatory Bowel Disease (IBD) Exhibit Proinflammatory Effects on Epithelial Cells and MacrophagesShuji Mitsuhashi, Linda Feldbrügge, Eva Csizmadia, et al.
Inflammatory Bowel Diseases|July 12, 2016
Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 StudyScott D Lee, David T Rubin, William J Sandborn, et al.
Inflammatory Bowel Diseases|September 26, 2017
Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational StudyXavier Roblin, Gilles Boschetti, Gérard Duru, et al.
Inflammatory Bowel Diseases|September 19, 2017
Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide CohortLorant Gonczi, Krisztina B Gecse, Zsuzsanna Vegh, et al.
Pageof 550